3
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Detección precoz de los trastornos del desarrollo (parte 2): trastornos del espectro autista Translated title: Early detection of developmental disorders (part 2): autistic spectrum disorders

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Resumen El autismo o trastorno del espectro autista es un trastorno del neurodesarrollo de base genética que consiste en la afectación de dos ejes mayores de la conducta: comunicación e interacción social y patrones de conducta repetitivos con intereses restrictivos. El cribado masivo de los trastornos del espectro autista para población de bajo riesgo daría lugar a un valor predictivo positivo estimado en nuestro medio de alrededor del 38%, con un exceso de derivación a servicios especializados y efecto de etiquetado sobre los pacientes. Se considera más adecuado el cribado en población de riesgo o ante la sospecha por parte de padres o profesionales. Recomendaciones de PrevInfad: 1) se sugiere no hacer cribado universal con escalas de tipo M-CHAT y variantes; 2) se propone hacer cribado con escalas tipo M-CHAT/R/F en individuos de alto riesgo.

          Translated abstract

          Abstract Autism or autistic spectrum disorder (ASD) is a neurodevelopment disorder, genetically based, that affects the two major exes of behaviour: communication and social interaction and repetitive patrons of behaviour with restrictive interests. ASD mass screening, in a low risk population, would produce a low positive predictive value of around 38%, with an excess of referrals to specialised services and label effect on patients. Screening on population at risk or under parents or professionals concern is considered more appropriate. PrevInfad recommendations: 1) we suggest not to do universal screening using scales such as M-CHAT and variations; 2) we recommend doing screening using scales such as M-CHAT to high risk individuals.

          Related collections

          Most cited references39

          • Record: found
          • Abstract: found
          • Article: not found

          Validation of the modified checklist for Autism in toddlers, revised with follow-up (M-CHAT-R/F).

          This study validates the Modified Checklist for Autism in Toddlers, Revised with Follow-up (M-CHAT-R/F), a screening tool for low-risk toddlers, and demonstrates improved utility compared with the original M-CHAT. Toddlers (N = 16,071) were screened during 18- and 24-month well-child care visits in metropolitan Atlanta and Connecticut. Parents of toddlers at risk on M-CHAT-R completed follow-up; those who continued to show risk were evaluated. The reliability and validity of the M-CHAT-R/F were demonstrated, and optimal scoring was determined by using receiver operating characteristic curves. Children whose total score was ≥ 3 initially and ≥ 2 after follow-up had a 47.5% risk of being diagnosed with autism spectrum disorder (ASD; confidence interval [95% CI]: 0.41-0.54) and a 94.6% risk of any developmental delay or concern (95% CI: 0.92-0.98). Total score was more effective than alternative scores. An algorithm based on 3 risk levels is recommended to maximize clinical utility and to reduce age of diagnosis and onset of early intervention. The M-CHAT-R detects ASD at a higher rate compared with the M-CHAT while also reducing the number of children needing the follow-up. Children in the current study were diagnosed 2 years younger than the national median age of diagnosis. The M-CHAT-R/F detects many cases of ASD in toddlers; physicians using the 2-stage screener can be confident that most screen-positive cases warrant evaluation and referral for early intervention. Widespread implementation of universal screening can lower the age of ASD diagnosis by 2 years compared with recent surveillance findings, increasing time available for early intervention.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Prevalence of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2010.

            (2014)
            Autism spectrum disorder (ASD). 2010. The Autism and Developmental Disabilities Monitoring (ADDM) Network is an active surveillance system in the United States that provides estimates of the prevalence of ASD and other characteristics among children aged 8 years whose parents or guardians live in 11 ADDM sites in the United States. ADDM surveillance is conducted in two phases. The first phase consists of screening and abstracting comprehensive evaluations performed by professional providers in the community. Multiple data sources for these evaluations include general pediatric health clinics and specialized programs for children with developmental disabilities. In addition, most ADDM Network sites also review and abstract records of children receiving special education services in public schools. The second phase involves review of all abstracted evaluations by trained clinicians to determine ASD surveillance case status. A child meets the surveillance case definition for ASD if a comprehensive evaluation of that child completed by a qualified professional describes behaviors consistent with the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) diagnostic criteria for any of the following conditions: autistic disorder, pervasive developmental disorder-not otherwise specified (including atypical autism), or Asperger disorder. This report provides updated prevalence estimates for ASD from the 2010 surveillance year. In addition to prevalence estimates, characteristics of the population of children with ASD are described. For 2010, the overall prevalence of ASD among the ADDM sites was 14.7 per 1,000 (one in 68) children aged 8 years. Overall ASD prevalence estimates varied among sites from 5.7 to 21.9 per 1,000 children aged 8 years. ASD prevalence estimates also varied by sex and racial/ethnic group. Approximately one in 42 boys and one in 189 girls living in the ADDM Network communities were identified as having ASD. Non-Hispanic white children were approximately 30% more likely to be identified with ASD than non-Hispanic black children and were almost 50% more likely to be identified with ASD than Hispanic children. Among the seven sites with sufficient data on intellectual ability, 31% of children with ASD were classified as having IQ scores in the range of intellectual disability (IQ ≤70), 23% in the borderline range (IQ = 71-85), and 46% in the average or above average range of intellectual ability (IQ >85). The proportion of children classified in the range of intellectual disability differed by race/ethnicity. Approximately 48% of non-Hispanic black children with ASD were classified in the range of intellectual disability compared with 38% of Hispanic children and 25% of non-Hispanic white children. The median age of earliest known ASD diagnosis was 53 months and did not differ significantly by sex or race/ethnicity. These findings from CDC's ADDM Network, which are based on 2010 data reported from 11 sites, provide updated population-based estimates of the prevalence of ASD in multiple communities in the United States. Because the ADDM Network sites do not provide a representative sample of the entire United States, the combined prevalence estimates presented in this report cannot be generalized to all children aged 8 years in the United States population. Consistent with previous reports from the ADDM Network, findings from the 2010 surveillance year were marked by significant variations in ASD prevalence by geographic area, sex, race/ethnicity, and level of intellectual ability. The extent to which this variation might be attributable to diagnostic practices, underrecognition of ASD symptoms in some racial/ethnic groups, socioeconomic disparities in access to services, and regional differences in clinical or school-based practices that might influence the findings in this report is unclear. ADDM Network investigators will continue to monitor the prevalence of ASD in select communities, with a focus on exploring changes within these communities that might affect both the observed prevalence of ASD and population-based characteristics of children identified with ASD. Although ASD is sometimes diagnosed by 2 years of age, the median age of the first ASD diagnosis remains older than age 4 years in the ADDM Network communities. Recommendations from the ADDM Network include enhancing strategies to address the need for 1) standardized, widely adopted measures to document ASD severity and functional limitations associated with ASD diagnosis; 2) improved recognition and documentation of symptoms of ASD, particularly among both boys and girls, children without intellectual disability, and children in all racial/ethnic groups; and 3) decreasing the age when children receive their first evaluation for and a diagnosis of ASD and are enrolled in community-based support systems.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              A systematic review of early intensive intervention for autism spectrum disorders.

              Early intensive behavioral and developmental interventions for young children with autism spectrum disorders (ASDs) may enhance developmental outcomes. To systematically review evidence regarding such interventions for children aged 12 and younger with ASDs. We searched Medline, PsycINFO, and ERIC (Education Resources Information Center) from 2000 to May 2010. Two reviewers independently assessed studies against predetermined inclusion/exclusion criteria. Two reviewers independently extracted data regarding participant and intervention characteristics, assessment techniques, and outcomes and assigned overall quality and strength-of-evidence ratings using predetermined criteria. Thirty-four unique studies met inclusion criteria. Seventeen studies were case series; 2 were randomized controlled trials. We rated 1 study as good quality, 10 as fair quality, and 23 as poor quality. The strength of the evidence overall ranged from insufficient to low. Studies of University of California Los Angeles/Lovaas-based interventions and variants reported clinically significant gains in language and cognitive skills in some children, as did 1 randomized controlled trial of an early intensive developmental intervention approach (the Early Start Denver Model). Specific parent-training approaches yielded gains in short-term language function and some challenging behaviors. Data suggest that subgroups of children displayed more prominent gains across studies, but participant characteristics associated with greater gains are not well understood. Studies of Lovaas-based approaches and early intensive behavioral intervention variants and the Early Start Denver Model resulted in some improvements in cognitive performance, language skills, and adaptive behavior skills in some young children with ASDs, although the literature is limited by methodologic concerns.
                Bookmark

                Author and article information

                Contributors
                Role: ND
                Role: ND
                Role: ND
                Role: ND
                Role: ND
                Role: ND
                Role: ND
                Role: ND
                Role: ND
                Role: ND
                Role: ND
                Journal
                pap
                Pediatría Atención Primaria
                Rev Pediatr Aten Primaria
                Asociación Española de Pediatría de Atención Primaria (Madrid, Madrid, Spain )
                1139-7632
                September 2018
                : 20
                : 79
                : 277-285
                Affiliations
                [7] Móstoles Madrid orgnameCentro de Salud Barcelona España
                [6] Madrid orgnameCentro de Salud Canillejas España
                [5] Valencia Valencia orgnameUniversitat de Valencia orgdiv1Unidad de Pediatría. orgdiv2Departamento de Pediatría, Obstetricia y Ginecología. Spain
                [10] Getafe Madrid orgnameCentro de Salud El Greco España
                [1] Zaragoza orgnameCentro de Salud Torrero La Paz España
                [3] Velilla de San Antonio Madrid orgnameCentro de Salud Mejorada del Campo España
                [11] Zaragoza orgnameCentro de Salud Delicias Sur España
                [4] Granada orgnameCentro de Salud Zaidín Sur España
                [8] Málaga orgnameCentro de Salud Trinidad España
                [9] Madrid orgnameCentro de Salud Villablanca España
                [2] Madrid orgnameHospital Universitario 12 de Octubre orgdiv1Servicio de Neonatología España
                [12] orgnameGrupo PreInfad/PAPPS España
                Article
                S1139-76322018000300016
                64a1ce28-d14d-492c-b5b9-455346f63deb

                This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

                History
                Page count
                Figures: 0, Tables: 0, Equations: 0, References: 58, Pages: 9
                Product

                SciELO Spain

                Categories
                Grupo PrevInfad/PAPPS Infancia y Adolescencia

                Tamizaje masivo,Trastorno del espectro autista,Trastornos generalizados del desarrollo infantil,Mass screening,Autism spectrum disorder,Child development disorders, pervasive

                Comments

                Comment on this article